期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

色素性隆突性皮肤纤维肉瘤(Bednar瘤)1例

下载PDF
导出
摘要 患者,男,52岁.发现左下肢包块20余年,无疼痛及其他不适,因近期无原因增大到门诊就诊.查体：患者全身状况良好,左侧下肢触及1.5 cm×1.5 cm肿块,质硬,活动差,无压痛,表面皮肤发红.病理检查：巨检 ：带皮组织（左下肢）一块,大小为2.5 cm×1.8 cm×0.8 cm,皮肤上有一大小为1.5 cm×1.3 cm×0.3 cm的灰黑色结节,表面无破溃,质中等.
作者 郑神英 李宁 余琦 张晓燕
机构地区 解放军
出处 《疑难病杂志》 CAS 2012年第2期143-143,共1页 Chinese Journal of Difficult and Complicated Cases
关键词 皮肤纤维肉瘤 隆突性 色素性 病例报告
分类号 R739.5 [医药卫生—肿瘤]
  • 相关文献

参考文献8

  • 1薛卫成,方志伟.软组织肿瘤[M].北京:北京大学医学出版社,2011:383-385.
  • 2Breuninger H, Sebastian G, Garbe C. Dermatoflbrosarcoma protuberans-an update [ J ]. J Dtsch Dermatol Ges,2004,2 ( 8 ) :661-667.
  • 3赖宽,李顺凡,吴志华.隆突性皮肤纤维肉瘤[J].岭南皮肤性病科杂志,2003,10(4):283-286. 被引量：3
  • 4Elgart GW, Hanly A. Bednar tumor occurring in a site of prior immuniza- tion : Immunochemieal findings and therapy [ J ]. J Am Aead Dermatol, 1999,40(2) :315-317.
  • 5Gooskens SL, Oranje AP, Van Adrichem LN, et al. Imatinib mesylate for children with dermatofibrosareoma [ J ]. Pediatr Blood Cancer, 2010,55 (2) :369-373.
  • 6Alam M, Husain S, Ratner D. Discussion of question 21-30 [ J ]. J Am Acad Dermato1,2001,45 (4) :486.
  • 7Goldblum JR. Giant cell fibroblasroma, dermatofibrosarcoma protuberans, and fibrosarcomatous change [ J ]. Pathology Case Review, 2002,7 ( 4 ) : 127-132.
  • 8大谷哲史,石井寬.線維肉腫樣病变さ伴つた隆起性皮膚線維肉腫肺転移の1例[J].日呼吸会誌,2008,46:253-257.

二级参考文献25

  • 1Sigel JE, Bergfeld WF, Goldblum JR. A morphologic study of dermatofibrosarcoma protuberans: expansion of a histologic profile. Journal of Cutaneous Pathology, 2000,27(4): 159 - 163.
  • 2Goldblum JR, Tuthill RJ. CD34 and Factor- XⅢa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.The American Journal of Dermatopathology, 1997, 19(2) : 147-153.
  • 3Goldblam JR. Giant cell fibroblastoma, dermatofibrosarcoma protuberans, and fibrosarcomatous change. Pathology Case Reviews, 2002, 7(4): 127-132.
  • 4Alam M, Husain S, Ratner D. Discussion of questions 21 - 30[Self- assessment: answers to self- assessment examination of the american academy of dermatology]. Journal of the American Academy of Dermatology, 2001, 45(3 (Part 1)): 486.
  • 5Eduardo C, Christopher F. Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatousvariant: clinicopathologic analysis of 5 cases. Journal of Cutaneous Pathology,1996, 23 (1):30-36.
  • 6Manabul S, Tsuyoshi I, Hajime H, et al. Dermatofibrosarcoma protuberans: An analysis of proliferative activity, DNA flow cytometry and p53 overexpression with emphasis on its progression. Pathology International, 1999, 49(9): 799-806.
  • 7Hisaoka M, Okamoto S, Morimitsu Y, et al. Dermatofibrosarcoma protuberans with fibrosarcomatous areas molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Virchows Arch, 1998,433: 323- 329.
  • 8Augusto O, Luca B, Giusto SL. Myxoid dermatofibrosarcoma protuberans: morphological, ultrastructural and immunohistochemical features. Journal of Cutaneous Pathology, 1998, 25 (7):386 - 393.
  • 9Roberto B, Elena I, Carlo C. Unusual features of primary dermatofibrosarcoma protuberans and its myxoid recurrence. Journal of Cutaneous Pathology, 1996, 23(3): 283- 287.
  • 10Maire G, Pedeutour F, Coindre JM. COL1A1 - PDGFB gene fusion demonstrates a common histogenetic origin for dermatofibrosarcoma protuberans and its granular cell variant. The American Journal of Surgical Pathology, 2002, 26(7): 932 -937.

共引文献4

疑难病杂志
2012年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部